Altimmune, Inc. (ALT) Tops Q1 EPS by 10c

Altimmune, Inc. (NASDAQ: ALT) reported Q1 EPS of ($0.40), $0.10 better than the analyst estimate of ($0.50).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• UBS Reiterates Buy Rating on Darden Restaurants (DRI) Ahead of Q1 Earnings
• Incyte (INCY) Reiterated at Neutral by Cantor Fitzgerald After Management Chat